U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07196748) titled 'A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis' on Sept. 22.
Brief Summary: The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and adolescent participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the colon becomes inflamed and develops tiny open ulcers).
Study Start Date: Oct. 23
Study Type: INTERVENTIONAL
Condition:
Colitis, Ulcerative
Intervention:
DRUG: Icotrokinra
Icotrokinr...